Cannabist Company Holdings Dirección

Dirección controles de criterios 3/4

El CEO de Cannabist Company Holdings' es David Hart , nombrado en Jan 2024, tiene una permanencia de menos de un año. compensación anual total es $1.71M, compuesta por 22% salario y 78% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.65% de las acciones de la empresa, por valor de $800.98K. La antigüedad media del equipo directivo y de la junta directiva es de 3.3 años y 4.2 años, respectivamente.

Información clave

David Hart

Chief Executive Officer (CEO)

US$1.7m

Compensación total

Porcentaje del salario del CEO	22.0%
Permanencia del CEO	less than a year
Participación del CEO	0.7%
Permanencia media de la dirección	3.5yrs
Promedio de permanencia en la Junta Directiva	4.4yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de David Hart en comparación con los beneficios de Cannabist Company Holdings?
Fecha	Compensación total	Salario	Ingresos de la empresa
Mar 31 2024	n/a	n/a	-US$173m
Dec 31 2023	US$2m	US$375k	-US$176m
Sep 30 2023	n/a	n/a	-US$403m
Jun 30 2023	n/a	n/a	-US$402m
Mar 31 2023	n/a	n/a	-US$427m
Dec 31 2022	US$4m	US$348k	-US$416m
Sep 30 2022	n/a	n/a	-US$169m
Jun 30 2022	n/a	n/a	-US$177m
Mar 31 2022	n/a	n/a	-US$141m
Dec 31 2021	US$2m	US$340k	-US$143m
Sep 30 2021	n/a	n/a	-US$131m
Jun 30 2021	n/a	n/a	-US$98m
Mar 31 2021	n/a	n/a	-US$104m
Dec 31 2020	US$2m	US$308k	-US$96m
Sep 30 2020	n/a	n/a	-US$81m
Jun 30 2020	n/a	n/a	-US$88m
Mar 31 2020	n/a	n/a	-US$98m
Dec 31 2019	US$7m	US$297k	-US$96m

Compensación vs. Mercado: La compensación total de David($USD1.71M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD661.60K).

Compensación vs. Ingresos: La compensación de David ha sido consistente con los resultados de la empresa en el último año.

CEO

David Hart (47 yo)

less than a year

Permanencia

US$1,707,655

Compensación

Mr. David J. Hart Joined The Cannabist Company Holdings Inc. (formerly known as Columbia Care Inc.) in 2016 and had been its Chief Operating Officer since 2018, until January 15, 2024 and served as its Pre...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Michael Abbott	Co-Founder & Chairman	5.2yrs	US$2.13m	sin datos
David Hart	Chief Executive Officer	less than a year	US$1.71m	0.66% $ 643.0k
Jesse Channon	President	less than a year	US$1.27m	0.40% $ 391.3k
Nicholas Vita	Co-Founder & Director	12.4yrs	US$520.00k	4.02% $ 3.9m
Derek Watson	Chief Financial Officer	2.4yrs	sin datos	0.23% $ 224.3k
Bryan Olson	Chief People & Administrative Officer	7.4yrs	sin datos	0.32% $ 311.7k
Lee Evans	Vice President of Investor Relations	3.5yrs	sin datos	sin datos
Kate Driscoll	Vice President of Compliance	no data	sin datos	sin datos
David Sirolly	Chief Legal Officer & General Counsel	3.4yrs	sin datos	0.21% $ 203.4k
Guy Hussussian	Chief Data Officer	6.4yrs	sin datos	sin datos

3.5yrs

Permanencia media

50.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de CBST.F se considera experimentado (3.3 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Michael Abbott	Co-Founder & Chairman	5.2yrs	US$2.13m	sin datos
Nicholas Vita	Co-Founder & Director	5.2yrs	US$520.00k	4.02% $ 3.9m
Jonathan May	Independent Lead Director	5.2yrs	US$186.36k	0.69% $ 672.2k
John Howard	Member of the Strategic Advisory Board	4.3yrs	US$13.38k	sin datos
Frank Savage	Independent Director	4.4yrs	US$168.49k	0.053% $ 52.4k
Julie Hill	Independent Director	3yrs	US$158.84k	0.044% $ 42.9k
Rosemary Mazanet	Director	less than a year	sin datos	0.46% $ 454.5k
Jeffrey Clarke	Independent Director	4.4yrs	US$173.86k	0.17% $ 170.4k
James Kennedy	Independent Director	5.2yrs	US$173.86k	0.45% $ 437.1k
David Solomon	Member of the Strategic Advisory Board	4.3yrs	US$10.75k	sin datos
Igor Gimelshtein	Board Observer	4yrs	US$27.50k	sin datos
Alison Worthington	Independent Director	3.6yrs	US$152.86k	0.035% $ 34.8k

4.4yrs

Permanencia media

60.5yo

Promedio de edad

Junta con experiencia: La junta directiva de CBST.F se considera experimentada (4.2 años de antigüedad promedio).

Cannabist Company Holdings Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

The Cannabist Company Holdings Inc., Annual General Meeting, Jun 26, 2024

the Cannabist Company Announces executive Changes

Columbia Care Inc. Announces Joining of Rosemary Mazanet to Board of Directors

Columbia Care Inc., Annual General Meeting, Nov 08, 2023

Columbia Care Inc. Appoints David Hart as President and Chief Operating Officer

Columbia Care Announces Resignation of Philip Goldberg as Director, Effective June 12, 2023

Recent updates

The Cannabist Company Holdings Inc. Announces Launch of Its Triple Seven Brand in New York and Florida

The Cannabist Company Holdings Inc., Annual General Meeting, Jun 26, 2024

The Cannabist Company Holdings Inc. to Report Q1, 2024 Results on May 09, 2024

The Cannabist Company Holdings Inc. announced that it has received $19.5 million in funding

The Cannabist Company Holdings Inc. announced that it has received $19.5 million in funding

The Cannabist Company Holdings Inc. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2023

The Cannabist Company Holdings Inc. to Report Q4, 2023 Results on Mar 13, 2024

the Cannabist Company Announces executive Changes

The Cannabist Company Holdings Inc. Announces Launch of Popular Classix and Seed & Strain Brands in Florida

The Cannabist Company Holdings Inc. (OTCPK:CBST.F) announces an Equity Buyback for 15,000,000 shares, for CAD 5 million.

The Cannabist Company Holdings Inc. (OTCPK:CBST.F) announces an Equity Buyback for 15,000,000 shares, for CAD 5 million.

The Cannabist Company Holdings Inc. to Report Q3, 2023 Results on Nov 14, 2023

The Cannabist Company Holdings Inc. announced that it has received $24.999978 million in funding

Columbia Care Inc. announced that it expects to receive $24.999978 million in funding

Columbia Care Inc. Announces Joining of Rosemary Mazanet to Board of Directors

Columbia Care Inc., Annual General Meeting, Nov 08, 2023

Columbia Care Inc. Appoints David Hart as President and Chief Operating Officer

Columbia Care to Delist from CSE

Cresco Labs Inc. (CNSX:CL) cancelled the acquisition of Columbia Care Inc. (CNSX:CCHW).

Columbia Care Announces Resignation of Philip Goldberg as Director, Effective June 12, 2023

Columbia Care Inc. Introduces New Line of Formulated Cannabis Tablets, PRESS 2.0

Combs Enterprises signed a definitive agreements to acquire Certain New York, Illinois, and Massachusetts assets of Cresco Labs Inc. and Columbia Care Inc. for approximately $190 million.

Columbia Care Inc. to Report Q3, 2022 Results on Nov 14, 2022

Columbia Care Inc. Introduces Hedy, a New Cannabis-Infused Edibles Brand

Columbia Care Inc. Launches First Pre-Rolls in New York Under Its Leading National Flower Brand, Seed & Strain

Columbia Care Inc. to Report Q2, 2022 Results on Aug 15, 2022

Columbia Care Inc., Annual General Meeting, Sep 20, 2022

Columbia Care Operationalizes Second Cultivation Facility in New Jersey and Expands Adult Use Hours At Both Garden State Cannabist Locations

Columbia Care Inc. Provides Earnings Outlook for the Year 2022

Columbia Care Inc. to Report Q1, 2022 Results on May 16, 2022

Columbia Care Announces Historic Launch of Adult Use Sales At Its Two New Jersey Cannabist Dispensaries

Columbia Care Inc. (CNSX:CCHW) acquired 49.9% stake in Access Bryant SPC.

Columbia Care Inc. announced that it has received $185 million in funding

Columbia Care Inc. to Report Q4, 2021 Results on Mar 15, 2022

Columbia Care Inc. (CNSX:CCHW) acquired Corsa Verde LLC for approximately $2.7 million.

Columbia Care Inc. announced that it has received $74.5 million in funding

Columbia Care Inc. announced that it expects to receive $74.5 million in funding

Columbia Care Inc. (CNSX:CCHW) entered into an agreement to acquire Medicine Man of Denver, Inc. from Family for $42 million.

Columbia Care Inc. (CNSX:CCHW) completed the acquisition of Green Leaf Medical, LLC.

Columbia Care Inc. Announces the Launch of Forage

Columbia Care Inc. Reaffirms Earnings Guidance for the Year 2021

Columbia Care Inc. Unveils National Retail Experience with Launch of Cannabist

Columbia Care Inc. Reaffirms Revenue Guidance for the Full Year of 2021

Columbia Care Inc. announced that it has received CAD 28.98 million in funding

Columbia Care Inc. announced that it expects to receive CAD 25.2 million in funding

Columbia Care Launches Adult-Use Sales in Arizona at its SWC Dispensaries

Columbia Care Inc. has completed a Follow-on Equity Offering in the amount of CAD 130.0075 million.

Columbia Care Inc. (CNSX:CCHW) acquired the Healing Center San Diego for approximately $15 million.

Columbia Care Inc. (CNSX:CCHW) signed a definitive agreement to acquire Green Leaf Medical, LLC for approximately $250 million.

Columbia Care Inc. (CNSX:CCHW) completed the acquisition of Project Cannabis.

Columbia Care, Inc. Appoints Alison Worthington to Its Board of Directors

Columbia Care Inc. announced that it has received $20.4 million in funding

Columbia Care Inc. to Report Q3, 2020 Results on Nov 12, 2020

Columbia Care Brings Consistency and Credibility to the Adult Use Cannabis Space with First National Lifestyle Brand Seed & Strain

Columbia Care Inc. (CNSX:CCHW) entered into a definitive agreement to acquire Project Cannabis for $69 million.

Columbia Care Inc. (OTCPK:CCHW.F) completed the acquisition of The Green Solution, LLC from Speidell family for approximately $130 million.

Columbia Care Inc. to Report Q2, 2020 Results on Aug 10, 2020

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad